CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for IMBiologics Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

IMBiologics Inc
260 Changnyong-daero Yeongtong
Phone: +82 3180678170p:+82 3180678170 SEONGNAM, 16229  South Korea Fax: +82 3180678169f:+82 3180678169
Business Summary
IMBiologics Inc is a Korea-based company primarily engaged in medical and pharmaceutical research and development business. As an innovative antibody drug development company, the Company develops differentiated treatments for autoimmune diseases and immuno-oncology based on optimal antibody modality production technology.
(Source: 6-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024-----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Chief Executive Officer, Founder GyongsikHa
Chief Financial Officer, Chief of Management Support WanjunKim
Chief Operating Officer, Chief Business Officer, Head of Business Operation InsooJung
Chief Technology Officer, Head of R&D Center ChungminLee
Chief Development Officer, Head of Development dept. ChihyePark

General Information
Outstanding Shares: 12,737,649 (As of 2/26/2026)
Fax Number: +82 3180678169


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, March 11, 2026